Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

10-24-2017 | Neuropathy | Review | Article

Treatment-Induced Neuropathy of Diabetes

Journal: Current Diabetes Reports

Author: Christopher H. Gibbons

Publisher: Springer US

Login to get access

Abstract

Purpose of Review

Treatment-induced neuropathy of diabetes (TIND) is an under-recognized iatrogenic painful sensory and autonomic neuropathy. This review highlights the clinical symptoms and signs, raises awareness of the cause, and provides education about prevention of TIND.

Recent Findings

TIND may be triggered by a rapid decline in the blood glucose levels following the use of insulin, oral hypoglycemic medications, or even diet only to control diabetes. This may be seen in up to 10% of patients with diabetic neuropathy and has the potential for significant long-term complications that could be avoided through careful disease management. Based on the available evidence, a decrease in the glycosylated hemoglobin A1C of more than 3 points in 3 months in individuals with chronic hyperglycemia increases the risk of developing TIND.

Summary

TIND is more common than previously suspected, and is tied to rates of glycemic control. Slower changes to glucose control are suggested, although there is no prospective data on disease prevention. Future research is necessary to guide treatment recommendations.
Literature
1.
Caravati CM. Insulin neuritis: a case report. VaMedMonthly. 1933;59:745–6.
2.
Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. AmJPhysiol. 1994;266(6 Pt 1):E980–E5.
3.
Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39(3):329–35.CrossRefPubMed
4.
Dabby R, Sadeh M, Lampl Y, Gilad R, Watemberg N. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2009;63(10):707–9.CrossRef
5.
Ellenberg M. Diabetic neuropathic cachexia. Diabetes. 1974;23:418–23.CrossRefPubMed
6.
Gade GN, Hofeldt FD, Treece GL. Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine. JAMA 1980;243(11):1160–1.
7.
Massey EW. Diabetic neuropathic cachexia and diabetic amyotrophy. Acta DiabetolLat. 1982;19(1):91–5.
8.
Blau RH. Diabetic neuropathic cachexia. Report of a woman with this syndrome and review of the literature. ArchInternMed. 1983;143(10):2011–2.
9.
Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P, et al. Acta Neuropathol(Berl). 1986;72:157–63.CrossRef
10.
Llewelyn JG, Thomas PK, Fonseca V, Dandona P. Acute painful diabetic neuropathy. Diabetes Care. 1988;11(9):748–9.CrossRefPubMed
11.
Knopp M, Srikantha M, Rajabally YA. Insulin neuritis and diabetic cachectic neuropathy: a review. Curr Diabetes Rev. 2013;9(3):267–74.CrossRefPubMed
12.
Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67(4):534–41.CrossRefPubMedPubMedCentral
13.
•• Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138(Pt 1):43–52. This is the first study describing the frequency of TIND in a referral population. This paper also links the rate of change in the HbA1C with the risk of complciations CrossRefPubMed
14.
CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. In: CDC, editor.: Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
15.
de Groot M, Golden SH, Wagner J. Psychological conditions in adults with diabetes. The American psychologist. 2016;71(7):552–62.CrossRefPubMedPubMedCentral
16.
• Colton PA, Olmsted MP, Daneman D, Farquhar JC, Wong H, Muskat S, et al. Eating disorders in girls and women with type 1 diabetes: a longitudinal study of prevalence, onset, remission, and recurrence. Diabetes Care. 2015;38(7):1212–7. An important publication on the frequency and relapse rates of eating disorders in diabetes CrossRefPubMed
17.
• Gibbons CH. Treatment induced neuropathy of diabetes—long term implications in type 1 diabetes. J Diabetes Complicat. 2017;31(4):715–20. The first long-term follow-up study of individuals with type 1 diabetes and TIND CrossRefPubMed
18.
Gibbons CH, Freeman R, Tecilazich F, Dinh T, Lyons TE, Gnardellis C, et al. The evolving natural history of neurophysiologic function in patients with well-controlled diabetes. Journal of the peripheral nervous system : JPNS. 2013;18(2):153–61.CrossRefPubMedPubMedCentral
19.
Takii M, Uchigata Y, Tokunaga S, Amemiya N, Kinukawa N, Nozaki T, et al. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of type 1 diabetic females with clinical eating disorders. IntJEatDisord. 2008;41(3):259–64.
20.
Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care. 1999;22(12):1956–60.CrossRefPubMed
21.
Peveler RC, Fairburn CG. Anorexia nervosa in association with diabetes mellitus—a cognitive-behavioural approach to treatment. Behav Res Ther. 1989;27(1):95–9.CrossRefPubMed
22.
Chantelau E, Meyer-Schwickerath R. Reversion of ‘early worsening’ of diabetic retinopathy by deliberate restoration of poor metabolic control. Ophthalmologica. 2003;217(5):373–7.CrossRefPubMed
23.
Group DR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. NEnglJ Med. 1993;329(14):977–86.CrossRef
24.
Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. CurrDiabRep. 2010;10(4):276–82.
25.
Group DR. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116(7):874–86.CrossRef
26.
Davis MD, Beck RW, Home PD, Sandow J, Ferris FL. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH insulin. ExpClinEndocrinolDiabetes. 2007;115(4):240–3.
27.
Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010;33(5):1090–6.CrossRefPubMedPubMedCentral
28.
Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119(22):2886–93.CrossRefPubMedPubMedCentral
29.
Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One. 2013;8(12):e84716.CrossRefPubMedPubMedCentral

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Image Credits